Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Medtronic
Chubb
QuintilesIMS
Federal Trade Commission
Harvard Business School

Generated: September 20, 2019

DrugPatentWatch Database Preview

Drugs in MeSH Category Cytochrome P-450 CYP2D6 Inhibitors

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva FLUOXETINE HYDROCHLORIDE fluoxetine hydrochloride TABLET;ORAL 075872-002 Jan 4, 2019 AB RX No No   Try a Free Trial   Try a Free Trial   Try a Free Trial
Marksans Pharma FLUOXETINE HYDROCHLORIDE fluoxetine hydrochloride CAPSULE;ORAL 075465-002 Jan 29, 2002 AB1 RX No No   Try a Free Trial   Try a Free Trial   Try a Free Trial
Hi Tech Pharma FLUOXETINE HYDROCHLORIDE fluoxetine hydrochloride SOLUTION;ORAL 075525-001 Jun 27, 2002 DISCN No No   Try a Free Trial   Try a Free Trial   Try a Free Trial
Lannett Co Inc FLUOXETINE HYDROCHLORIDE fluoxetine hydrochloride SOLUTION;ORAL 077849-001 Feb 9, 2007 AA RX No No   Try a Free Trial   Try a Free Trial   Try a Free Trial
Sciegen Pharms Inc FLUOXETINE HYDROCHLORIDE fluoxetine hydrochloride CAPSULE;ORAL 204597-001 Mar 16, 2015 AB1 RX No No   Try a Free Trial   Try a Free Trial   Try a Free Trial
Mylan Pharms Inc FLUOXETINE HYDROCHLORIDE fluoxetine hydrochloride CAPSULE;ORAL 075577-002 Jan 29, 2002 DISCN No No   Try a Free Trial   Try a Free Trial   Try a Free Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Teva
Julphar
Fish and Richardson
Accenture
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
Copyright 2002-2019 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
Generic Entry Opportunies 2019 - 2020
 NCE-1 Generic Application Dates 2019 - 2020
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2019, www.DrugPatentWatch.com.

Links

Follow DrugPatentWatch:

DrugPatentWatch reviews